The onset of autonomous driving has provided fertile ground for discussions about ethics in recent years. These discussions are heavily documented in the scientific literature and have mainly revolved around extreme traffic situations depicted as moral dilemmas, i.e. situations in which the autonomous vehicle (AV) is required to make a difficult moral choice. Quite surprisingly, little is known about the ethical issues in focus by the AV industry. General claims have been made about the struggles of companies regarding the ethical issues of AVs but these lack proper substantiation. As private companies are highly influential on the development and acceptance of AV technologies, a meaningful debate about the ethics of AVs should take into account the ethical issues prioritised by industry. In order to assess the awareness and engagement of industry on the ethics of AVs, we inspected the narratives in the official business and technical reports of companies with an AV testing permit in California. The findings of our literature and industry review suggest that: (i) given the plethora of ethical issues addressed in the reports, autonomous driving companies seem to be aware of and engaged in the ethics of autonomous driving technology; (ii) scientific literature and industry reports prioritise safety and cybersecurity; (iii) scientific and industry communities agree that AVs will not eliminate the risk of accidents; (iv) scientific literature on AV technology ethics is dominated by discussions about the trolley problem; (v) moral dilemmas resembling trolley cases are not addressed in industry reports but there are nuanced allusions that unravel underlying concerns about these extreme traffic situations; (vi) autonomous driving companies have different approaches with respect to the authority of remote operators; and (vii) companies seem invested in a lowest liability risk design strategy relying on rules and regulations, expedite investigations, and crash/collision avoidance algorithms.
The pursuit of AMAs is complicated. Disputes about the development, design, moral agency, and future projections for these systems have been reported in the literature. This empirical study explores these controversial matters by surveying (AI) Ethics scholars with the aim of establishing a more coherent and informed debate. Using Q-methodology, we show the wide breadth of viewpoints and approaches to artificial morality. Five main perspectives about AMAs emerged from our data and were subsequently interpreted and discussed: (i) Machine Ethics: The Way Forward; (ii) Ethical Verification: Safe and Sufficient; (iii) Morally Uncertain Machines: Human Values to Avoid Moral Dystopia; (iv) Human Exceptionalism: Machines Cannot Moralize; and (v) Machine Objectivism: Machines as Superior Moral Agents. A potential source of these differing perspectives is the failure of Machine Ethics to be widely observed or explored as an applied ethic and more than a futuristic end. Our study helps improve the foundations for an informed debate about AMAs, where contrasting views and agreements are disclosed and appreciated. Such debate is crucial to realize an interdisciplinary approach to artificial morality, which allows us to gain insights into morality while also engaging practitioners.
Using two legal research platforms, we identified 193 stem-cell-related legal cases that were decided in US courts. Classifying the cases by category, we examined historical trends in the types of legal cases related to stem cells. Major types of cases involved plaintiffs seeking to overturn denial of health insurance coverage decisions, disputes related to intellectual property, false advertising, breaches of contract, exposure to hazardous agents, regulatory decisions, stem cell procedures and professional standard of care, use of stems cells in research, and public funding of embryonic stem cell research. Analysis of court decisions provides insight into contemporary and historical legal issues related to stem cells and reveals the breadth of stem-cell-related cases now being decided by US courts.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.